BVI, VirtuaLens will showcase new technologies at ESCRS 2025
At the ESCRS meeting, cataract surgeons can get familiar with BVI's Virtuoso platform and VirtuaLens' immersive VR IOL simulator
(Image credit: ©spainter_vfx/AdobeStock)
BVI and VirtuaLens will both showcase their latest technology systems during the upcoming 43rd Congress of the European Society of Cataract and Refractive Surgeons (ESCRS) being held 12-15 September in Copenhagen, Denmark.
BVI Medical
Ophthalmic device company BVI recently announced the unveiling of its newest surgical platform, Virtuoso, in the European market.1 This European debut is planned jointly for the 2025 ESCRS meeting and during the European Society of Retina Specialists (EURETINA) Congress, which was held earlier this month in France.
“Virtuoso represents a significant leap in surgical technology, bringing efficiency and control to both anterior and posterior segment procedures,” Shervin Korangy, president and CEO of BVI, said in a press release.
“With Virtuoso, we are expanding our presence in the equipment segment of ophthalmology and look forward to watching millions of patients benefit from this technology. The excitement from the ophthalmic community for this much-anticipated introduction is palpable.”
Combining advanced technologies across fluidics control, vitreoretinal applications, ultrasound delivery and usability, Vitreoso offers a high-performance platform with control and accuracy. This new device also offers a thoughtful footprint to maximise space in the operating room.2
“Virtuoso has a very novel fluidics concept, maintaining target IOP throughout all procedure steps, from phaco to I/A, uniquely fusing the control of a flow pump with the efficacy of a pressure pump,” said Dr Tommaso Rossi of UPMC Salvator Mundi International Hospital, Rome, Italy.2
According to the press release from BVI, Virtuoso is “addressing the needs of a growing number of ambulatory surgical centers and hospitals seeking flexible, cost-effective platforms.” Built into one platform, the device is designed to provide versatility in multi-specialty centers, offering market-leading applications across cataract, vitrectomy and combined procedures.
Commercial availability for Virtuoso will begin in select European markets, with a global rollout planned according to appropriate market approvals.
VirtuaLens
Continuing in the cataract tech space, VirtuaLens announced the unveiling of its new virtual reality (VR) platform, which allows cataract patients to explore and compare different IOL options before surgery.3
“VirtuaLens represents a paradigm shift in cataract patient counseling—patients can now experience a side-by-side preview, showing how different strategies and lenses affect their vision in everyday situations,” Robert Osher, MD, said. Dr Osher is a professor of ophthalmology at the College of Medicine of the University of Cincinnati, and medical director emeritus of the Cincinnati Eye Institute.
As previously reported by Ophthalmology Times®, the company made note of the platform’s need due to patients often facing difficulty visualising how different lens types may affect their daily lives after surgery.3
The VirtuaLens VR IOL Simulator can help patients and their families understand the benefits of monofocal, multifocal and premium lenses in realistic, lifestyle-based scenarios. This includes exploring patients’ priorities and vision goals, such as safe night driving, sports without glasses, comfortable reading or long hours at the computer without eye strain. The VirtuaLens platform provides a way for patients to compare how each lens type may enhance their vision in these contexts, making the choice personal and informed.4
"VirtuaLens represents a paradigm shift in cataract patient counseling,” Dr Osher said, describing how this informed patient experience can lead to better surgical outcomes.4
“Patients can now experience a side-by-side preview, showing how different strategies and lenses affect their vision in everyday situations," Dr Osher continued. "The surgeon will benefit from time saved and knowing that the best possible education has been provided to help the patient make a confident decision."
Reference:
BVI Medical, Inc. BVI Unveils Virtuoso® – A Novel Dual-Function Surgical Platform for Cataract and Vitreoretinal Procedures. GlobeNewswire News Room. Published September 3, 2025. https://www.globenewswire.com/news-release/2025/09/03/3143764/0/en/BVI-Unveils-Virtuoso-A-Novel-Dual-Function-Surgical-Platform-for-Cataract-and-Vitreoretinal-Procedures.html?utm_source=chatgpt.com
Filkins K. BVI unveils new Virtuoso surgical platform. Modern Retina. Published September 3, 2025. Accessed September 10, 2025. https://www.modernretina.com/view/bvi-unveils-new-virtuoso-surgical-platform
Mott M. VirtuaLens Launches Immersive Virtual Reality IOL Simulator, Transforming Cataract Patient Education and Lens Selection - VirtuaLens. VirtuaLens. Published September 3, 2025. Accessed September 10, 2025. https://virtualens.health/virtualens-launches-immersive-virtual-reality-iol-simulator-transforming-cataract-patient-education-and-lens-selection/
Crago SM. VirtuaLens launches virtual reality tool: Immersive IOL Simulator. Ophthalmology Times. Published September 4, 2025. Accessed September 10, 2025. https://www.ophthalmologytimes.com/view/virtualens-launches-virtual-reality-tool-immersive-iol-simulator
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
